Evidence map›Paper›PMID 41432436›Full record

ArticlePlant biotechnology journal2026

Convergent Evolution and De Novo Reconstitution of Apiin Biosynthesis.

Zhen Xu, Zheng-Shuang Zhu, Hai-Zhu Jia, Jian-Qiang Kong

Abstract read
In one paragraph

Article in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Phytochemicals fromFoods (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhen XuInstitute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, (State Key Laboratory of Bioactive Substance and Function of Natural Medicines, NHC Key Laboratory of Biosynthesis of Natural Products & CAMS Key Laboratory of Enzyme and Biocatalysis of Natural Drugs), Beijing, China.
Zheng-Shuang ZhuInstitute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, (State Key Laboratory of Bioactive Substance and Function of Natural Medicines, NHC Key Laboratory of Biosynthesis of Natural Products & CAMS Key Laboratory of Enzyme and Biocatalysis of Natural Drugs), Beijing, China.
Hai-Zhu JiaInstitute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, (State Key Laboratory of Bioactive Substance and Function of Natural Medicines, NHC Key Laboratory of Biosynthesis of Natural Products & CAMS Key Laboratory of Enzyme and Biocatalysis of Natural Drugs), Beijing, China.
Jian-Qiang KongInstitute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, (State Key Laboratory of Bioactive Substance and Function of Natural Medicines, NHC Key Laboratory of Biosynthesis of Natural Products & CAMS Key Laboratory of Enzyme and Biocatalysis of Natural Drugs), Beijing, China.

Funding

CAMS Innovation Fund for Medical Sciences 2021-I2M-1-029National Key Research and Development Program of China 2020YFA0908000
6 · The paper itself

Abstract

Apiin, an active flavonoid apioside, occurs in phylogenetically distant plants, such as parsley and chilli pepper (Capsicum annuum L.). Its sporadic distribution suggests the existence of convergent apiin biosynthesis; however, the molecular mechanisms underlying this convergence remain unclear. In this study, apiin biosynthesis in chilli pepper was comprehensively clarified. The structural genes involved in the biosynthesis of apigenin 7-O-glucoside, a precursor of apiin, were conserved using a homology-based approach. An apiin-biosynthetic apiosyltransferase (ApiGT), CaApiGT1, was identified from Capsicum annuum using comparative transcriptomic technology and in vitro enzymatic assays. Despite its strict specificity for the UDP-apiose donor, CaApiGT1 recognised multiple acceptors, including flavonoid 7-, 4'-and 3-O-glycosides. The sequence identity between CaApiGT1 and other apiin-biosynthetic ApiGTs was below 30%. CaApiGT1 (UGT79) and other apiin-biosynthetic ApiGTs (UGT94) belong to different UDP-dependent glycosyltransferase (UGT) families. These evidences collectively confirmed that CaApiGT1 is a novel ApiGT. Thus, convergent apiin biosynthesis was essentially caused by the convergent evolution of ApiGTs, rather than by distinct biosynthetic pathways between phylogenetically distant plants. Subsequently, CaApiGT1 was expressed in Escherichia coli to construct an engineered strain (EAA3PF) for apiin synthesis from apigenin. Additionally, an engineered Saccharomyces cerevisiae strain (YA3P) was developed for de novo apigenin synthesis. Co-cultivation of EAA3PF and YA3P reconstitutes the apiin biosynthetic pathway. This study provides new insight into the molecular convergence and de novo reconstitution of apiin biosynthesis.

Indexed as

ApigeninCapsicumEvolution, MolecularGlycosyltransferasesPhylogenyPlant ProteinsApigeninGlycosyltransferasesPlant ProteinsApiinCapsicum annuumco‐cultureUDP‐apioseUDP‐apiosyltransferase

Identifiers

PMID41432436
PMCPMC13140228

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.